Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Minimizing spending doesn’t have to be a challenge. Explore effortless ways to keep your expenses low while enjoying life.
22,570 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
In a briefing, the legal chief puts clarity on the bill's fate, pointing to sub-50% odds this Senate session due to s...
XRP trades near $1.50 in mid-May 2026 as traders weigh a potential move to $3 this year. Regulatory clarity and liqui...
Global markets sold off after leaders offered little concrete trade progress. Investors warn that day one of talks ma...
New data from the 2025 P-Fin Index shows women trail men by eight points in financial literacy, with sharper gaps in ...
Lime’s IPO plans put micro-mobility in the spotlight. This article explains why a seasoned investor might prefer an e...
The Bay Area’s luxury housing market tightens as AI-powered wealth concentrates in upscale ZIP codes. Meanwhile, more...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Beam Global is shaping the clean-energy charging space. In this piece, we break down what Q1 2026 earnings might reve...
With winter looming, Ryanair faces higher jet fuel costs. The airline’s CFO says contingency plans are in place as fu...
A 64-year-old couple skipped a long-term care policy at 58 and now faces six-figure potential costs as health and ins...
As markets climb in 2026, investors are embracing purpose-driven planning. Experts say writing your obituary help can...